Nemaura Medical, Inc. operates as a holding company. The firm engages in the provision of medical device research. It manufactures and commercializes glucose monitoring system, named sugarBEAT. The sugarBEAT consists of a disposable adhesive skin-patch connected to a rechargeable wireless transmitter that displays glucose readings at regular five minute intervals with the use of a mobile app. The company was founded by Dewan Fazlul Hoque Chowdhury on December 24, 2013 and is headquartered in New York, NY.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Nemaura Medical Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Nemaura Medical Inc market cap is $4,000.00.
What is the 52-week high for Nemaura Medical Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Nemaura Medical Inc 52 week high is $0.0298 as of October 10, 2025.
What is the 52-week low for Nemaura Medical Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Nemaura Medical Inc 52 week low is $0.00 as of October 10, 2025.
What is Nemaura Medical Inc stock price today?
Nemaura Medical Inc stock price today is $0.0001.
What was Nemaura Medical Inc stock price yesterday?
Nemaura Medical Inc stock price yesterday was $0.0001.
What is the 50-day moving average of Nemaura Medical Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Nemaura Medical Inc 50-day moving average is $0.0001.